Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sana Biotechnology, Inc.

2.81
-0.0600-2.09%
Post-market: 2.820.0100+0.36%19:43 EDT
Volume:5.97M
Turnover:16.89M
Market Cap:633.81M
PE:-3.18
High:2.90
Open:2.90
Low:2.79
Close:2.87
Loading ...

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Sana Biotechnology (SANA)

TIPRANKS
·
26 Jun

Sana Biotechnology Announces Positive Diabetes Study Results

TIPRANKS
·
24 Jun

Sana Biotechnology Shares Climb on Positive Diabetes Study Results

Dow Jones
·
23 Jun

BRIEF-Sana Biotechnology Says Six-Month Results Show Islet Cells Safe & Functional

Reuters
·
23 Jun

Sana Biotechnology Inc - Six-Month Results Show Sana's Islet Cells Safe and Functional

THOMSON REUTERS
·
23 Jun

Sana Biotechnology Inc. Files Initial Statement of Beneficial Ownership for Director Robert L. Rosiello

Reuters
·
10 Jun

Sana Biotechnology Announces Six-Month Clinical Results of Hypoimmune Pancreatic Islet Cell Therapy at ADA Scientific Sessions

Reuters
·
10 Jun

Sana Biotechnology Announces Invited Oral Presentation at the 85TH Annual American Diabetes Association Scientific Sessions

THOMSON REUTERS
·
10 Jun

Sana Biotechnology Inc. Concluded Annual Stockholders Meeting

Reuters
·
07 Jun

Umaisyah's killing, teen overdose deaths show devastating cost of drugs on society and families: Shanmugam

CNA
·
16 May

Sana Biotechnology Inc. to Present at BofA Securities 2025 Healthcare Conference

Reuters
·
13 May

Sana Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Sana Biotechnology Inc - Co Enters Sales Agreement With TD Securities (USA) Llc for $119 Million Stock Offering - SEC Filing

THOMSON REUTERS
·
09 May

Sana Biotechnology Inc - Terminates Prior Sales Agreement After $30.6 Million Proceeds - SEC Filing

THOMSON REUTERS
·
09 May

Sana Biotechnology Enters New $119M Sales Agreement

TIPRANKS
·
09 May

Sana Biotechnology Q1 Adj. EPS $(0.20) Beats $(0.23) Estimate

Benzinga
·
09 May

BRIEF-Sana Biotechnology Q1 Operating Expenses USD 50.63 Million

Reuters
·
09 May

Sana Biotechnology Inc: Q1 2025 Cash Position of $104.7 Mln; Expected Cash Runway Into 2026

THOMSON REUTERS
·
09 May

Press Release: Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates

Dow Jones
·
09 May

Sana Biotechnology Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
02 May